Diarrhea News and Research

Latest Diarrhea News and Research

Study of hospital-acquired infection yields potential therapeutic target

Study of hospital-acquired infection yields potential therapeutic target

Sucampo receives supplement approval from FDA for AMITIZA

Sucampo receives supplement approval from FDA for AMITIZA

Eisai announces FDA acceptance of AcipHex NDA for priority review

Eisai announces FDA acceptance of AcipHex NDA for priority review

Novartis to highlight key data from extensive oncology portfolio at SABCS and ASH meeting

Novartis to highlight key data from extensive oncology portfolio at SABCS and ASH meeting

CSL, PharmaJet partner for needle-free delivery of Afluria influenza vaccine

CSL, PharmaJet partner for needle-free delivery of Afluria influenza vaccine

Exelixis announces FDA approval of COMETRIQ for treatment of medullary thyroid cancer

Exelixis announces FDA approval of COMETRIQ for treatment of medullary thyroid cancer

European Medicines Agency accepts Exelixis’ COMETRIQ MAA for review

European Medicines Agency accepts Exelixis’ COMETRIQ MAA for review

AstraZeneca receives FDA approval for Cometriq to treat medullary thyroid cancer

AstraZeneca receives FDA approval for Cometriq to treat medullary thyroid cancer

FDA grants Seattle Genetics orphan drug designation for ADCETRIS to treat mycosis fungoides

FDA grants Seattle Genetics orphan drug designation for ADCETRIS to treat mycosis fungoides

Bowel cancer and GIST patients could benefit from novel oral drug

Bowel cancer and GIST patients could benefit from novel oral drug

Regorafenib able to control resistant gastrointestinal stromal tumor

Regorafenib able to control resistant gastrointestinal stromal tumor

Global health programs need to address community needs

Global health programs need to address community needs

Nasal spray sufficient for allergic rhinitis in Japanese patients

Nasal spray sufficient for allergic rhinitis in Japanese patients

Hebron introduces Florax DS Diarrhea Relief and Ready-to-Drink probiotic

Hebron introduces Florax DS Diarrhea Relief and Ready-to-Drink probiotic

Bevacizumab ruled out for stage III colorectal cancer

Bevacizumab ruled out for stage III colorectal cancer

Abacus Diagnostica’s GenomEra C. difficile assay receives CE mark

Abacus Diagnostica’s GenomEra C. difficile assay receives CE mark

Positive results from Genentech Avastin plus temozolomide Phase III study on glioblastoma

Positive results from Genentech Avastin plus temozolomide Phase III study on glioblastoma

Ebola, Marburg and Lassa viruses must be designated as emerging diagnoses

Ebola, Marburg and Lassa viruses must be designated as emerging diagnoses

Lone star tick causes alpha-gal meat sensitivity in regional population

Lone star tick causes alpha-gal meat sensitivity in regional population

Soligenix receives FDA Fast Track designation for SGX203 to treat pediatric Crohn's disease

Soligenix receives FDA Fast Track designation for SGX203 to treat pediatric Crohn's disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.